How do you pay?

How to pay the least

Ask for the cash price

Jubbonti

Jubbonti is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Jubbonti’s cash price, and one or two other pharmacies too.
  2. Jubbonti’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameJubbonti
Authorized genericdenosumab
Regular genericdenosumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Jubbonti?
The original
–
–

Brand nameThe maker’s card

Jubbonti Co-pay Program (Sandoz One Source)

Savings card from Sandoz

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

Sign up on jubbonti.com 

In the maker’s words

“Eligible, commercially insured people may pay as little as $0 for Jubbonti. Terms and Conditions apply.a…”

From the maker’s offer on jubbonti.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Jubbonti itself, from the same company, sold without the brand name, and usually for less. For now Jubbonti is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Jubbonti is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

Jubbonti is a RANK ligand (RANKL) inhibitor indicated for treatment:

  • of postmenopausal women with osteoporosis at high risk for fracture.
  • to increase bone mass in men with osteoporosis at high risk for fracture.
  • of glucocorticoid-induced osteoporosis in men and women at high risk for fracture.
  • to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer.
  • to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

Source: the FDA label for Jubbonti (Sandoz Inc), October 30, 2025. Full label on DailyMed 

Good to know